Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 102 entries
View as:

Phase 1 Thorough QT Study in Young Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00485667 Org: User:
Start: 06/30/07 End: 08/31/07 Due: 08/31/08

Study to Evaluate the Safety and Tolerability of FX201 in Patients with Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT04119687 Org: User:
Start: 03/02/20 End: 11/28/26 Due: 11/28/27

Probe Configuration and Time-Temperature Dose Ranging for Understanding of Skin Lesion Effects

Phase: N/A Priority: Normal
NCT ID: NCT01681745 Org: User:
Start: 06/01/12 End: 04/01/15 Due: 04/01/16

Prospective Study Evaluating the Treatment of Hyperdynamic Forehead Wrinkles

Phase: N/A Priority: Normal
NCT ID: NCT01984619 Org: User:
Start: 09/30/13 End: 09/30/14 Due: 09/30/15

Study Evaluating the Treatment of Forehead and/or Glabellar Lines With the CRYO-TOUCH III Device

Phase: N/A Priority: Normal
NCT ID: NCT01808742 Org: User:
Start: 11/30/12 End: 08/31/14 Due: 08/31/15

A Study to Evaluate the Safety and Effectiveness of the Cryo-Touch II Device for the Treatment of Forehead and/or Glabellar Lines

Phase: N/A Priority: Normal
NCT ID: NCT01447342 Org: User:
Start: 09/30/11 End: 08/31/12 Due: 08/31/13

Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT02357459 Org: User:
Start: 01/31/15 End: 01/31/16 Due: 01/31/17

Study of Pain Control in Hemorrhoidectomy

Phase: N/A Priority: Normal
NCT ID: NCT00890721 Org: User:
Start: 05/31/09 End: 11/30/09 Due: 11/30/10

Safety and Pharmacokinetics Study of Redosing EXPAREL in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02210247 Org: User:
Start: 08/31/14 End: 09/30/14 Due: 09/30/15

Phase 1, Dose Escalation Study to Evaluate of Safety, Pharmacokinetics and Pharmacodynamics of Liposomal Bupivacaine 13.3 Administered Via a Single Intrathecal Injection to Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05456490 Org: User:
Start: 04/18/23 End: 02/27/25 Due: 02/27/26

Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery

Phase: N/A Priority: Normal
NCT ID: NCT06271265 Org: User:
Start: 03/29/24 End: 07/31/25 Due: 07/31/26

A Phase 3 Study to Evaluate the Safety and Efficacy of SKY0402 in Subjects Undergoing Total Knee Arthroplasty

Phase: N/A Priority: Normal
NCT ID: NCT00745290 Org: User:
Start: 08/31/08 End: 02/28/09 Due: 02/28/10

A Prospective Study Evaluating the Treatment of Forehead and/or Glabellar Lines With the Cryo-Touch IV Device

Phase: N/A Priority: Normal
NCT ID: NCT01801826 Org: User:
Start: 01/31/13 End: 12/31/14 Due: 12/31/15

Evaluate the Safety and Efficacy of EXPAREL When Administered Via Infiltration Into the TAP vs. Bupivacaine Alone in Subjects Undergoing Elective C-Sections

Phase: N/A Priority: Normal
NCT ID: NCT03176459 Org: User:
Start: 06/01/17 End: 12/04/18 Due: 12/04/19

Study of EXPAREL in Patients Undergoing Breast Augmentation

Phase: N/A Priority: Normal
NCT ID: NCT01582490 Org: User:
Start: 04/30/12 End: 11/30/12 Due: 11/30/13

Cryo-Touch III Refinement Study Investigational Plan

Phase: N/A Priority: Normal
NCT ID: NCT01379365 Org: User:
Start: 06/30/11 End: 12/31/14 Due: 12/31/15

Observational Study to Assess Long-Term Follow-Up of Breast Augmentation Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01076686 Org: User:
Start: 02/28/10 End: 03/31/10 Due: 03/31/11

A Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal MA402S23B504

Phase: N/A Priority: Normal
NCT ID: NCT01509807 Org: User:
Start: 01/31/12 End: 10/31/12 Due: 10/31/13

Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of EXPAREL® Administered Via a Single Intrathecal Injection to Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04173611 Org: User:
Start: 06/08/20 End: 12/07/20 Due: 12/07/21

Study of the MyoScience Tissue Remodeling Device for Facial Rejuvenation

Phase: N/A Priority: Normal
NCT ID: NCT00842062 Org: User:
Start: 02/28/09 End: 01/31/12 Due: 01/31/13

Study to Characterize the Local Duration of Exposure From FX006 in Patients With Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT02003365 Org: User:
Start: 11/30/13 End: 04/30/14 Due: 04/30/15

Cryo-Touch II for the Treatment of Wrinkles

Phase: N/A Priority: Normal
NCT ID: NCT01167140 Org: User:
Start: 07/31/10 End: 04/30/11 Due: 04/30/12

Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00003073 Org: User:
Start: 02/28/97 End: - Due: -

Study to Evaluate a Procedure for Intra-articular Injection of FX006 in Patients With Osteoarthritis of the Hip

Phase: N/A Priority: Normal
NCT ID: NCT04065074 Org: User:
Start: 07/30/19 End: 12/30/19 Due: 12/30/20

Treatment With Iovera° for Total Knee Arthroplasty (TKA) Post-Operative Pain

Phase: N/A Priority: Normal
NCT ID: NCT03327220 Org: User:
Start: 11/06/17 End: 03/27/19 Due: 03/27/20